I-FOM INJECTION

Composition

Each 100 ml solution contains
Oxytetracycline as HCl 30gm
Flunixn Meglumin 2gm

Indications

For the treatment of acute respiratory disease caused by oxytetracycline sensitive Mannheimia (Pasteurella) haemolytica and Pasteurella multocida where an anti-inflammatory and anti-pyretic effect is required. Hexasol should only be used after sensitivity testing of the isolated pathogens involved.

Contra-indications

Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding or where there is hypersensitivity to one of the ingredients of the product. Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Do not use in cases of known resistance to tetracyclines. Special precautions for use in animals:
Use in any animals less than 6 weeks of age or in aged animals may involve additional risk due to the anti-prostaglandin effects of flunixin on renal function. If such use cannot be avoided, animals may require careful clinical management.

Due to the high geographical variability of the bacterial sensitivity of oxytetracycline, the use of the product should be based on susceptibility testing and take into account official and local antimicrobial policies.
Special precautions to be taken by the person administering the medicinal products to animals. In the case of accidental self injection, if an allergic reaction occurs, medical advice should be sought. In case of accidental contact with skin or eyes, rinse with copious amounts of water. If persistent irritation occurs, seek medical advice .A transient, usually mild reaction at the injection site may be observed following intramuscular administration and may persist for up to 30 days.
In certain cases a mild increase in body temperature may be noted following treatment. Any increase is transient and will be unlikely to occur in animals already suffering from pyrexia. Studies in cattle at the normal dose rate and twice the normal dose rate have shown transient and dose dependent reactions at the injection site leading to increased associated enzymatic activity.
The use of tetracyclines during the period of tooth and bone development may lead to discolouration. Use during pregnancy, lactation or lay
Flunixin and oxytetracycline showed no evidence of embryotoxicity or teratogenicity in laboratory animals. The safety of the product was not assessed in pregnant and lactating animals. The use of the product is not recommended in pregnant and lactating animals.

Dosage & Administration

Indicated for deep intramuscular administration to cattle. The recommended dosage is 2 mg/kg flunixin and 30 mg/kg oxytetracycline (equivalent to 1 ml per 10 kg bodyweight).
This product is recommended for single administration only. Maximum volume per injection site: 15 ml.
Overdose (symptoms, emergency procedures, antidotes), if necessary
Administered to cattle at 4 mg/kg flunixin and 60 mg/kg oxytetracycline (twice the recommended dose) has been shown to be well tolerated. At twice the recommended dose, transient dysentery with or without apathy can occur. These symptoms resolve spontaneously without treatment within 48/72 hours. A transient usually mild reaction at the injection site may be observed following intramuscular administration and may persist beyond the withdrawal period.

Withdrawal Period

Meat and offal: 28days

Not for use in cattle producing milk for human consumption. Packing:
10ml, 50ml and 100ml.